| 产品描述: | TNG348 is an orally available allosteric inhibitor of the ubiquitin-specific protease USP1. TNG348 specifically and efficiently inhibits the activity of USP1, inhibiting its deubiquitination of proliferative PCNA and FANCD2, thereby disrupting the DNA repair process. TNG348 has inhibitory activity against breast and ovarian cancers carrying BRCA1/2 mutations and other homologous recombination defects (HRD) . |
| 靶点: |
JNK1 |
| 体内研究: |
TNG348 (30 nM,300 nM) 对 BRCA1/2 突变细胞系展现出选择性细胞毒性,其与 PARP 抑制剂联合使用时,在 BRCA1/2 突变和 HRD + 细胞系中表现出协同增效作用。 TNG348 通过抑制 USP1,致使单泛素化 PCNA 和 FANCD2 水平上升,从而干扰 DNA 修复过程。 |
| 保存条件: |
-80°C 6个月;-20°C 1个月 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.657 ml |
8.285 ml |
16.569 ml |
| 5 mM |
0.331 ml |
1.657 ml |
3.314 ml |
| 10 mM |
0.166 ml |
0.828 ml |
1.657 ml |
| 50 mM |
0.033 ml |
0.166 ml |
0.331 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |